Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Doxorubicin
... 5.8% over the analysis period 2024-2030. Breast Cancer Application, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$374.1 Million by the end of the analysis period. ... Read More
-
Contract Research Organization Services (CROs)
... Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Clinical Research Services, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$76.7 ... Read More
-
CNS Therapeutics
... CAGR of 7.3% over the analysis period 2024-2030. Neurodegenerative Diseases Therapeutics, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$75.9 Billion by the end of the ... Read More
-
Allergy Diagnostics
... CAGR of 10.0% over the analysis period 2024-2030. Allergy Diagnostics Assay Kits, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$4.5 Billion by the end of ... Read More
-
Corporate Wellness
... CAGR of 6.5% over the analysis period 2024-2030. Health Risk Assessment, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$27.9 Billion by the end of the ... Read More
-
Bone Growth Stimulators
... at a CAGR of 4.9% over the analysis period 2024-2030. Stimulation Devices, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$855.7 Million by the end of ... Read More
-
Sex Toys
... CAGR of 7.9% over the analysis period 2024-2030. Adult Vibrators, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$36.8 Billion by the end of the analysis ... Read More
-
Postpartum Hemorrhage (PPH) Treatment Devices
... Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Uterine Balloon Tamponade, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$521.7 ... Read More
-
Clear Aligners
... CAGR of 23.8% over the analysis period 2024-2030. Adult Clear Aligners, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$14.9 Billion by the end of the ... Read More
-
Cartilage Repair / Cartilage Regeneration
... Billion by 2030, growing at a CAGR of 15.1% over the analysis period 2024-2030. Cell-based Treatment Modality, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$2.3 ... Read More
-
Colposcopy
... 3.9% over the analysis period 2024-2030. Optical Colposcopy, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$580.3 Million by the end of the analysis period. Growth ... Read More
-
Cranial Fixation and Stabilization Systems
... Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Cranial Stabilization Systems, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$987.5 ... Read More
-
Dermatoscopes
... 13.1% over the analysis period 2024-2030. Contact Dermatoscope, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth ... Read More
-
Fertility Testing
... CAGR of 6.3% over the analysis period 2024-2030. Ovulation Predictor Kits, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$571.1 Million by the end of the ... Read More
-
Heart Valve Repair and Replacement Devices
... reach US$40.9 Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2024-2030. Transcatheter Surgery, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach ... Read More
-
Human Papillomavirus (HPV) Testing
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$919.4 Million ... Read More
-
Cervical Total Disc Replacement Devices
... Billion by 2030, growing at a CAGR of 18.3% over the analysis period 2024-2030. Metal-on-Biocompatible Material, one of the segments analyzed in the report, is expected to record a 19.2% CAGR and reach US$9.4 Billion ... Read More
-
Chemotherapy-induced Nausea and Vomiting Drugs
... Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Serotonin Receptor Antagonist, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$2.0 ... Read More
-
Bulk Paclitaxel
... CAGR of 8.5% over the analysis period 2024-2030. Semi-Synthetic Paclitaxel API, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$139.1 Million by the end of the ... Read More
-
Breast Cancer Screening
... at a CAGR of 5.1% over the analysis period 2024-2030. Imaging Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$4.8 Billion by the end of ... Read More
-
Breast Implants
... CAGR of 6.0% over the analysis period 2024-2030. Silicone Implants, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$4.2 Billion by the end of the analysis ... Read More
-
Cancer Gene Therapy
... at a CAGR of 20.9% over the analysis period 2024-2030. Oncolytic Virotherapy, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$4.3 Billion by the end of ... Read More
-
Rare Endocrine Disease Treatment
... 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. Acromegaly Indication, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$5.7 Billion by the ... Read More
-
Spinal Trauma Devices
... at a CAGR of 5.6% over the analysis period 2024-2030. Internal Fixation Devices, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$4.9 Billion by the end ... Read More
-
Radiology Information Systems
... at a CAGR of 7.4% over the analysis period 2024-2030. Integrated Systems, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$1.3 Billion by the end of ... Read More
Research Assistance
